Acadia Pharmaceuticals reported $310M in Cash and Equivalent for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 310M 137M
Adamas Pharmaceuticals ADMS:US $ 3750M 350M
Alexion Pharmaceuticals ALXN:US $ 2825M 510M
ALKERMES ALKS:US $ 240.87M 51.86M
Alnylam Pharmaceuticals ALNY:US $ 496.7M 84.12M
Biogen BIIB:US $ 2224.8M 160.1M
Biomarin Pharmaceutical BMRN:US $ 818.9M 342.27M
Bristol Myers Squibb BMY:US $ 19934M 4117M
Corcept Therapeutics CORT:US $ 58M 26M
Cytokinetics CYTK:US $ 200.81M 139.68M
Eisai 4523:JP Y 226308M 27936M
Eli Lilly And LLY:US $ 2365.1M 666.1M
Gw Pharmaceuticals GWPH:US $ 480.33M 2.77M
Intercept Pharmaceuticals ICPT:US $ 50.78M 9.37M
Johnson & Johnson JNJ:US $ 8485M 6957M
Neurocrine Biosciences NBIX:US $ 415M 228M
Pfizer PFE:US $ 1801M 350M
Prothena PRTA:US $ 314.52M 19.42M
Ptc Therapeutics PTCT:US $ 158.46M 35.17M
Sarepta Therapeutics SRPT:US $ 1639M 125M
Seattle Genetics SGEN:US $ 919.45M 802.13M
Ultragenyx Pharmaceutical RARE:US $ 335.64M 37.45M
Vanda Pharmaceuticals VNDA:US $ 95.3M 30.36M
Vertex Pharmaceuticals VRTX:US $ 4831.33M 1237.92M
YTE INCY:US $ 1326.73M 283.49M
Zogenix ZGNX:US $ 61M 163M